Two technical founders with a vision to transform biologics.
Who we are
Joshua Holter, MS
Co-Founder & CEO
Josh is a translational scientist with over a decade of experience spanning target selection through commercialization. After training at Washington University and Johns Hopkins, he contributed to multiple INDs for AAV gene therapies and supported two BLAs for biologics at companies including 4DMT, Iris Medicine, Sangamo, and BioMarin. His broad perspective on the therapeutic landscape guides MoAb’s path from discovery to clinic.
Sam Verbanic, Phd
Co-Founder & CSO
Sam is a synthetic biologist with 10+ years of experience at the intersection of computational and experimental biology. Before co-founding MoAb, he trained at Vassar, UCSB, and UCLA, and lead modernization of AAV discovery platforms at 4D Molecular Therapeutics as Associate Director, Synthetic Biology.His deep expertise in machine-guided, high-throughput discovery drives MoAb’s development of best-in-class minibinders.
Contact us
Interested in working together? Fill out some info and we will be in touch shortly. We can’t wait to hear from you!